But investors were not convinced, sending Sanofi's shares sharply lower in early business on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table. The deal "looks logical, but expensive", with …
Exscientia has announced that it has agreed a strategic research collaboration and licence option agreement with Sanofi in the high-interest area of metabolic disease, which could be worth up to €250m. The Company said: Delivery …
Activist investor Dan Loeb’s pressure on Nestle SA to sell its stake in L’Oreal SA could lead to the unwinding of another long-standing investment: L’Oreal’s 10.4 billion-euro ($11.6 billion) holding in French drugmaker Sanofi.
Sanofi SA (ADR) (NYSE:SNY) is the world’s No. 5 pharmaceutical company. It has over 100 manufacturing sites in 41 countries and has 110,000 employees in 100 countries. Its five top divisions do $40 billion in sales every year, and it …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Shares of Sanofi slid last week following news of the company’s bid for takeover of another pharmaceutical company, with shares falling 7 percent to a Friday close of $40.98 per share. Sanofi announced a bid for Medivation, even after the …
"Consequently the company has reduced prices of such products. This will have an adverse impact on the sales and profitability of the company," it added. Sanofi India stock was trading at Rs 4,380, up 1.36 per cent, on BSE.